An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.
A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the "list" price.
Faced with high U.S. prices for prescription drugs, some Americans cross the border to buy insulin pens and other meds. At least 1 insurer reimburses flights to the border to make such purchases easy.
Legal analysts say the decision to overturn Maryland's law could slow momentum for other states that are attempting to take action to curb high drug costs.
After decades of hope and disappointment, doctors have now been able to treat several different types of genetic conditions by giving each patient a healthy version of their defective gene.
These two older drugs, nitroprusside and isoproterenol, are frequently used in emergency and intensive care situations and have no direct alternatives, say cardiologists.
Some members of Congress say the U.S. government should use the patent rights it owns for any drugs that were developed with federal grants to drive down the prices of those drugs.
A spokesman said Tuesday that President Trump does want Medicare to be able to directly negotiate prescription drug prices with drugmakers. Analysts disagree about how much difference that would make.
Consumers often blame drug companies for the rapidly rising costs of some commonly used generic drugs. But changes made by insurers influence the price of these drugs, too, it turns out.
Some companies have bought the patents for old drugs, then abruptly upped the prices — from $13 per pill to $750 in one case. Irate senators call it price gouging.
The hormone that controls blood sugar among diabetics is one of the oldest medicines used today. But more than 90 years after its discovery, a low-cost version is no longer available in the U.S.
